Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
03/2012
03/06/2012US8128924 Methods for using a three-dimensional stromal tissue to promote angiogenesis
03/06/2012US8128922 Superior molecular vaccine linking the translocation domain of a bacterial toxin to an antigen
03/06/2012US8128920 IL-18BPb and IL-18BPd ( interleukin-18 binding protein isoform b and d ) that does not bind IL-18 for treating chronic neurodegenerative disease is selected from multiple sclerosis (MS), Alzheimer's disease (AD), Parkinson's disease (PD), Huntington's disease (HD) or amyotrophic lateral sclerosis (ALS)
03/06/2012US8128906 Stabilized uncoated particles of reversed liquid crystalline phase materials
03/06/2012US8128905 Stabilized uncoated particles of reversed liquid crystalline phase materials
03/06/2012US8128589 Apparatus and methods for enzymatic debridement of skin lesions
03/06/2012CA2530632C Inhalable formulations for treating pulmonary hypertension and methods of using same
03/06/2012CA2487734C Treatment with cytokines for alzheimer's disease
03/06/2012CA2483707C Microparticles bearing cells and active substances
03/06/2012CA2445664C Use of il-18 inhibitors for treating or preventing cns injuries
03/06/2012CA2442694C Osteoprotegerin in milk
03/06/2012CA2434831C Polypeptide drug substances
03/06/2012CA2290944C Pgc-1, a novel brown fat ppar.gamma. coactivator
03/06/2012CA2253924C Vasoactive amine binding molecules
03/06/2012CA2202408C Nucleotide sequences of hiv-1 type (or subtype) o retrovirus antigens
03/03/2012CA2751306A1 Methods for controlling blood-glucose levels in insulin-requiring subjects
03/01/2012WO2012027690A1 Control of biofilm formation
03/01/2012WO2012027652A2 Methods and compositions for treating inflammation
03/01/2012WO2012027611A2 INNOVATIVE DISCOVERY OF THERAPEUTIC, DIAGNOSTIC, AND ANTIBODY COMPOSITIONS RELATED TO PROTEIN FRAGMENTS OF TYROSYL-tRNA SYNTHETASES
03/01/2012WO2012027555A2 Glycated cd59 peptides, their preparation, and uses thereof
03/01/2012WO2012027514A2 Compositions and methods for cardiac therapy
03/01/2012WO2012027411A2 Compositions and uses of materials with high antimicrobial activity and low toxicity
03/01/2012WO2012027379A2 Interleukin-13 receptor alpha 2 peptide-based brain cancer vaccines
03/01/2012WO2012027324A2 Treatment for neoplastic diseases
03/01/2012WO2012027287A1 Nutritional products including pea protein hydrolysates
03/01/2012WO2012027285A1 Nutritional products having improved organoleptic properties
03/01/2012WO2012027200A2 Epitope therapy for infectious diseases
03/01/2012WO2012027170A1 Methods for repairing tissue damage using protease-resistant mutants of stromal cell derived factor-1
03/01/2012WO2012027065A2 Combination therapy for treatment of disease
03/01/2012WO2012026988A2 Dendrimeric peptides, pharmaceutical compositions and methods of using the same
03/01/2012WO2012026712A2 Pharmaceutical composition for preventing or treating immune diseases or inflammatory diseases, containing stem cells treated with nod2 agonist or cultured product thereof
03/01/2012WO2012026575A1 Muscle-enhancing agent
03/01/2012WO2012026526A1 Hemokinin-1 receptor and hemokinin-1-derived peptide
03/01/2012WO2012025925A1 Methods of improving transplantation using sdf-1alpha
03/01/2012WO2012025921A1 Compositions for gastric delivery of active agents
03/01/2012WO2012025746A1 Medical use of heparin-binding egf-like growth factor (hb-egf)
03/01/2012WO2012025651A1 Biomaterial comprising osteostatin for osseous regeneration and tissue engineering
03/01/2012WO2012024817A1 Whole egg protein peptides, preparation method and use thereof
03/01/2012WO2012024784A1 Cell-protective peptides and uses thereof
03/01/2012WO2012024767A1 Improved enteric active substance delivery
03/01/2012WO2012003398A8 Protein precursors as prodrugs
03/01/2012WO2011161531A4 Pharmaceutical composition containing goserelin for in-situ implant
03/01/2012WO2011154349A3 Fgf21 analogues and derivatives
03/01/2012WO2011139986A3 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of arginyl-trna synthetases
03/01/2012WO2011137540A8 Gfi1b modulation and uses thereof
03/01/2012WO2011133504A3 Nanozymes, methods of making nanozymes, and methods of using nanozymes
03/01/2012WO2011122916A9 Composition for increasing trail sensitivity, containing an inhibitor for inhibiting the expression or activity of tip41 which is a trail sensitizer target gene
03/01/2012WO2011119628A3 Compositions and methods for self-adjuvanting vaccines against microbes and tumors
03/01/2012WO2011069038A3 Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
03/01/2012WO2011060534A8 Trim5alpha mutants and uses thereof
03/01/2012WO2009036188A3 Insulin-like growth factor binding protein 7 for treatment of cancer
03/01/2012WO2003053332A3 Composition and method for treating viral infection
03/01/2012US20120054910 Antipathogenic Proteins and Methods of Use
03/01/2012US20120054879 HCV Coreceptor and Methods of Use Thereof
03/01/2012US20120053234 Hepcidin Binding Nucleic Acids
03/01/2012US20120053230 TREATMENT OF NEUROLOGICAL DISORDERS BY dsRNA ADMINISTRATION
03/01/2012US20120053228 Splice-region antisense composition and method
03/01/2012US20120053131 Methods of predicting medically refractive ulcerative colitis (mr-uc) requiring colectomy
03/01/2012US20120053130 Composition for enhancing absorption of a drug and method
03/01/2012US20120053129 Target-activated cell/tissue-penetrating peptide for delivery of impermeable compounds and use thereof
03/01/2012US20120053128 Method of inhibiting angiogenesis
03/01/2012US20120053127 Targeted delivery of botulinum toxin to the sphenopalatine ganglion
03/01/2012US20120053126 Injection Paradigm for Administration of Botulinum Toxins
03/01/2012US20120053125 Phosphatase inhibitor protein-1 as a regulator of cardiac function
03/01/2012US20120053124 Binder for c-reactive protein
03/01/2012US20120053123 Natriuretic polypeptides having mutations within their disulfide rings
03/01/2012US20120053122 Method for the prophylaxis or treatment of flushing
03/01/2012US20120053121 Administration of HB-EGF for the Protection of Enteric Neurons
03/01/2012US20120053120 Treatment of subarachnoid hemorrhage with apo e analogs
03/01/2012US20120053119 Therapeutic method for increasing pancreatic beta cell mass
03/01/2012US20120053118 Methods for affecting body composition using amylin agonists
03/01/2012US20120053117 Pharmaceutical composition, drug screening method and method for treating malaria
03/01/2012US20120053116 Scytovirin domain 1 related polypeptides
03/01/2012US20120053115 Lantibiotic Carboxyamide Derivatives With Enhanced Antibacterial Activity
03/01/2012US20120053114 Method
03/01/2012US20120053113 MANUFACTURE OF INTER-ALPHA-INHIBITOR (IaIp) FROM PLASMA
03/01/2012US20120053112 Methods and compositions related to the regulation of goblet cell differentiation, mucus production and mucus secretion
03/01/2012US20120052484 Methods of diagnosing cervical cancer
03/01/2012US20120052132 Compositions and methods for treatment of body weight conditions
03/01/2012US20120052130 Gpr 119 modulators
03/01/2012US20120052116 Immunogenic epitopes of ngep antigen
03/01/2012US20120052110 Methods and compositions for promoting wound healing
03/01/2012US20120052104 Polypeptides and Antibacterial or Antiseptic Use of Same
03/01/2012US20120052094 Agonists of Neurotrophin Receptors and Their Use as Medicaments
03/01/2012US20120052084 Staphylococcus aureus proteins and nucleic acids
03/01/2012US20120052083 MUTANT CyaA POLYPEPTIDES AND POLYPEPTIDE DERIVATIVES SUITABLE FOR THE DELIVERY OF IMMUNOGENIC MOLECULES INTO A CELL
03/01/2012US20120052080 Interleukin-13 receptor alpha 2 peptide-based brain cancer vaccines
03/01/2012US20120052077 Therapeutic modulation of vaginal epithelium boundary lubrication
03/01/2012US20120052069 Fgf21 mutants and uses thereof
03/01/2012US20120052067 Activin-actrii antagonists and uses for increasing red blood cell levels
03/01/2012US20120052065 Methods of treatment using ctla4 mutant molecules
03/01/2012US20120052058 Methods of managing the blood coagulation and pharmaceutical compositions related thereto
03/01/2012US20120052057 method for selecting responders to blockade of integrin receptors
03/01/2012US20120052055 Method of treating thrombocytopenia
03/01/2012US20120052053 Compositions and methods for the treatment of altered alpha-synuclein function
03/01/2012US20120052048 Antibacterial phage, phage peptides and methods of use thereof
03/01/2012US20120052046 Phosphoramidate Derivatives of Guanosine Nucleoside Compunds for Treatment of Viral Infections
03/01/2012US20120052045 Compositions and methods for modulating ischemic injury
03/01/2012US20120052044 Uses of mammalian cytokine; related reagents
03/01/2012US20120052043 Chemokine-Chaperone Fusion Proteins
1 ... 352 353 354 355 356 357 358 359 360 361 362 363 364 365 366 367 368 369 370 371 372 ... 3163